News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
282,478 Results
Type
Article (15023)
Company Profile (300)
Press Release (267149)
Multimedia
Podcasts (78)
Webinars (11)
Section
Business (79973)
Career Advice (162)
Deals (13352)
Drug Delivery (39)
Drug Development (50884)
Employer Resources (31)
FDA (5890)
Job Trends (5177)
News (145556)
Policy (10284)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (921)
Accelerated approval (19)
Adcomms (15)
Allergies (81)
Alliances (21817)
ALS (124)
Alzheimer's disease (1107)
Antibody-drug conjugate (ADC) (241)
Approvals (6090)
Artificial intelligence (259)
Autoimmune disease (110)
Automation (9)
Bankruptcy (105)
Best Places to Work (4571)
BIOSECURE Act (6)
Biosimilars (101)
Biotechnology (230)
Bladder cancer (101)
Brain cancer (45)
Breast cancer (344)
Cancer (3134)
Cardiovascular disease (238)
Career advice (147)
Career pathing (7)
CAR-T (217)
CDC (5)
Cell therapy (563)
Cervical cancer (14)
Clinical research (43795)
Collaboration (1153)
Company closure (2)
Compensation (591)
Complete response letters (39)
COVID-19 (1104)
CRISPR (86)
C-suite (551)
Cystic fibrosis (112)
Data (4329)
Denatured (15)
Depression (92)
Diabetes (254)
Diagnostics (1389)
Digital health (10)
Diversity (5)
Diversity, equity & inclusion (9)
Drug discovery (187)
Drug pricing (48)
Drug shortages (3)
Duchenne muscular dystrophy (213)
Earnings (31675)
Editorial (25)
Employer branding (4)
Employer resources (29)
Events (51758)
Executive appointments (623)
FDA (7656)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (9)
Frontotemporal dementia (22)
Funding (982)
Gene editing (182)
Generative AI (21)
Gene therapy (486)
GLP-1 (506)
Government (1192)
Grass and pollen (3)
Guidances (166)
Healthcare (6629)
HIV (18)
Huntington's disease (43)
IgA nephropathy (74)
Immunology and inflammation (191)
Immuno-oncology (39)
Indications (66)
Infectious disease (1208)
Inflammatory bowel disease (155)
Inflation Reduction Act (10)
Influenza (38)
Intellectual property (167)
Interviews (18)
IPO (7350)
IRA (12)
Job creations (867)
Job search strategy (129)
JPM (40)
Kidney cancer (9)
Labor market (22)
Layoffs (243)
Leadership (9)
Legal (1405)
Liver cancer (41)
Longevity (11)
Lung cancer (419)
Lymphoma (250)
Machine learning (24)
Management (7)
Manufacturing (376)
MASH (130)
Medical device (2701)
Medtech (2710)
Mergers & acquisitions (6626)
Metabolic disorders (724)
Multiple sclerosis (102)
NASH (13)
Neurodegenerative disease (230)
Neuropsychiatric disorders (70)
Neuroscience (2026)
Neurotech (1)
NextGen: Class of 2026 (2038)
Non-profit (872)
Now hiring (30)
Obesity (329)
Opinion (125)
Ovarian cancer (131)
Pain (102)
Pancreatic cancer (161)
Parkinson's disease (233)
Partnered (12)
Patents (301)
Patient recruitment (328)
Peanut (43)
People (26698)
Pharmaceutical (44)
Pharmacy benefit managers (6)
Phase 1 (15498)
Phase 2 (20347)
Phase 3 (12887)
Pipeline (3248)
Policy (90)
Postmarket research (855)
Preclinical (6540)
Press Release (30)
Prostate cancer (145)
Psychedelics (50)
Radiopharmaceuticals (239)
Rare diseases (647)
Real estate (1451)
Recruiting (12)
Regulatory (10086)
Reports (19)
Research institute (976)
Resumes & cover letters (18)
Rett syndrome (24)
RNA editing (21)
RSV (16)
Schizophrenia (123)
Series A (182)
Series B (135)
Service/supplier (1)
Sickle cell disease (77)
Special edition (18)
Spinal muscular atrophy (119)
Sponsored (15)
Startups (2006)
State (1)
Stomach cancer (5)
Supply chain (32)
Tariffs (18)
The Weekly (62)
Vaccines (334)
Venture capital (69)
Weight loss (173)
Women's health (26)
Worklife (2)
Date
Last 7 days (345)
Last 30 days (1207)
Last 365 days (17838)
2026 (1654)
2025 (18140)
2024 (20619)
2023 (22478)
2022 (26882)
2021 (27859)
2020 (23412)
2019 (16271)
2018 (11795)
2017 (13786)
2016 (11881)
2015 (14389)
2014 (10426)
2013 (7513)
2012 (7566)
2011 (7657)
2010 (7448)
Location
Africa (155)
Alabama (65)
Alaska (2)
Arizona (71)
Arkansas (5)
Asia (18352)
Australia (3118)
California (7087)
Canada (1839)
China (773)
Colorado (247)
Connecticut (252)
Delaware (235)
Europe (39242)
Florida (911)
Georgia (209)
Hawaii (2)
Idaho (17)
Illinois (395)
India (36)
Indiana (161)
Iowa (8)
Japan (234)
Kansas (80)
Kentucky (9)
Louisiana (7)
Maine (11)
Maryland (759)
Massachusetts (5591)
Michigan (110)
Minnesota (248)
Mississippi (3)
Missouri (32)
Montana (16)
Nebraska (5)
Nevada (32)
New Hampshire (22)
New Jersey (1649)
New Mexico (13)
New York (1762)
North Carolina (826)
North Dakota (6)
Northern California (3479)
Ohio (177)
Oklahoma (11)
Oregon (24)
Pennsylvania (1277)
Puerto Rico (9)
Rhode Island (25)
South America (216)
South Carolina (9)
Southern California (2812)
Tennessee (40)
Texas (905)
United States (23394)
Utah (96)
Virginia (137)
Washington D.C. (37)
Washington State (593)
West Virginia (1)
Wisconsin (45)
282,478 Results for "cdr therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
CDR-Life Appoints Dimitrios Chondros, MD, as Chief Medical Officer
February 4, 2026
·
2 min read
Press Releases
Boehringer Ingelheim and CDR-Life Expand Collaboration Efforts with Global Licensing Agreement for CDR111, an Antibody-Based Trispecific M-gager® for Autoimmune Diseases
November 5, 2025
·
3 min read
Press Releases
CDR-Life Presents Early Clinical Data Demonstrating Pharmacodynamic Activity of CDR404, a Novel Antibody-Derived T Cell Engager Targeting MAGE-A4+ Solid Tumors
October 23, 2025
·
3 min read
CDR-Life Announces Initiation of CDR404 Phase 1 Trial for Treatment of Solid Tumors at ASCO
CDR-Life Inc. today announced the initiation of enrollment for the Phase 1 trial of CDR404, its lead program in development as a precision immunotherapy for solid tumors.
May 29, 2024
·
1 min read
Press Releases
CDR-Life Announces CDR609 as New T-Cell Engager Clinical Candidate Targeting LGR5, a Highly Cancer-specific Surface Antigen Widely Expressed on Common Solid Tumor
June 26, 2025
·
2 min read
CDR-Life Announces Pipeline Expansion of Highly Tumor-Targeted T Cell Engagers
CDR-Life Inc. today announced an expansion of its pipeline of novel T cell engagers (TCE) with the addition of CDR813 and CDR505.
June 25, 2024
·
2 min read
Dassault Systèmes and CDR-Life Collaborate to Accelerate Scientific Innovation for Cancer Therapies
Dassault Systèmes announced it collaborated with CDR-Life, a Swiss biotherapeutics company, to accelerate CDR-Life’s development of next-generation highly tumor-selective immunotherapies using CDR-Life’s proprietary M-gager® platform.
March 12, 2024
·
4 min read
Press Releases
CDR-Life Appoints Pascal Touchon to the Board of Directors to Support Continued Growth and Advancement of Next Generation T Cell Engager Platform
May 28, 2025
·
2 min read
CDR-Life to Present at 6th Annual Cell Engager Summit
CDR-Life Inc. today announced that Chief Medical Officer Swethajit Biswas, MD, FRCP, will co-lead a seminar at the 6th Annual Cell Engager Summit, occurring May 21-23 in Boston.
May 21, 2024
·
2 min read
Press Releases
CDR-Life Announces Fifth Milestone Achievement with Boehringer Ingelheim in Geographic Atrophy
February 26, 2025
·
2 min read
1 of 28,248
Next
